EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Experimental and Clinical Psychopharmacology, published bimonthly by the American Psychological Association in the United States, serves as a premier peer-reviewed platform dedicated to the rigorous investigation of psychopharmacological phenomena. With the ISSN 1064-1297, this subscription-based journal is indexed in the Science Citation Index (SCI) and categorized within the psychology and pharmacology sections of the Chinese Academy of Sciences journal ranking, reflecting its standing as a high-quality publication in the field. The journal’s scope encompasses both experimental and clinical dimensions of psychopharmacology, featuring original research on the effects of psychoactive substances on behavior, cognition, and emotion, as well as the neuropharmacological mechanisms underlying drug abuse, addiction treatment, and withdrawal. By maintaining strict editorial standards, the journal attracts a specialized audience of researchers and clinicians interested in the intersection of pharmacology and mental health, offering a vital resource for those seeking to advance understanding in this niche yet critical area of scientific inquiry.